Beckman Laser Institute
  • About Us
      • About Us
      • Mission & Vision
      • Message From the Founding Director
      • History
      • By the Numbers
      • Employment
      • News
  • Medical Clinic
      • Medical Clinic
      • Conditions & Treatments
      • Why Choose Us
      • Clinical Research Protocols
      • Our Physicians
      • Our Clinic Team
  • Research
      • Research
    • Core Research
      • Modeling & Computation
      • Multimodal Endoscopy
      • Microscopy & Microbeams
      • Diffuse Optical Imaging
      • Laser Therapy
    • Research Programs
      • COVID-19 RESEARCH
      • Medical Applications
      • Laser Microbeam Program (LAMP)
      • Wearable Sensors
    • Shared Resources
      • Shared UCI Access Resources
  • Education & Outreach
      • Education & Outreach
      • Prospective Students
      • Access to Careers in Engineering and Sciences (ACES)
      • Publications
      • Mechanical Ventilation Amid COVID
      • Leaders in Light
      • Multiscale Biophotonics Training Program
      • Events
      • LASER Magazine
      • Course Catalog
  • Industry
      • Industry
      • Photonic Incubator
      • Technology Transfer
      • Patents
      • Convergence Optical Sciences Initiative (COSI)
      • Corporate Partners
      • Advisory Board
  • People
      • People
      • Our Faculty
      • Our Founders
      • Directory
      • Our Research Team
      • Our Research Management Team
      • Our Administrative Team
  • Giving
      • Giving
      • Donate Online
  • How to Give
  • Ways to Give
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Archive for category: News

Four Biomedical Engineering Faculty Named AIMBE Fellows

February 18, 2022/ News /by Gabrielle Comfort

By Lori Brandt, UCI Samueli School of Engineering

Four UC Irvine biomedical engineering faculty – Elliot Botvinick, Michelle Digman, Chang Liu and Wendy Liu –  are among 152 medical and biological engineers who were inducted into the American Institute for Medical and Biological Engineering’s College of Fellows Class of 2022.

Each was selected for their outstanding contributions in their field. A prestigious professional distinction, the College of Fellows represents the top 2% of medical and biological engineers in the country.

“Induction into AIMBE is a well-deserved honor for these faculty, two of whom are also members of the Edwards Lifesciences Foundation Cardiovascular Innovation and Research Center (CIRC),” said Naomi Chesler, director of the CIRC and an Inclusive Excellence Professor of biomedical engineering, who nominated all four. “It is both a recognition of their research accomplishments and impact to date and an opportunity to contribute to biomedical science policy and public understanding of biomedical science and engineering on a larger stage.”

Professor Botvinick was recognized for work in biophotonics and its use in medical devices and the study of biophysics in cell-tissue interactions. In his research, Botvinick studies the relationship between mechanical stresses on cells and molecular signaling or mechanotransduction.

“I am honored to become an AIMBE fellow,” he said. “I will continue to devote my life to improving our understanding of how cells sense tissues and to develop new technologies to aid in the treatment of diabetes. As an AIMBE fellow, I will embark on the next chapter of my career, which is to invent, develop, test and commercialize unprofitable medical devices for underserved groups, particularly in pediatrics. And more importantly, to build and share the resources for other scientists to do the same.”

Associate Professor Digman was acknowledged for her contributions to the development of and applications to fluorescence fluctuation spectroscopy and fluorescence lifetime imaging microscopy. Digman’s research focuses on quantitative spatial and temporal correlation spectroscopy, protein dynamics during cell migration, characterizing metabolic alterations in cells and tissues, and developing novel imaging technologies.

“I am honored to join my colleagues as an AIMBE fellow,” said Digman. “I want to thank my past and present group members, as well as collaborators for making so many things possible during this research journey. I’m also excited to support AIMBE’s mission of advocacy in the field of biomedical engineering. In addition, I want to thank Naomi Chesler, who was vital in all of our nominations, for her support and efforts in contributing to enhancing equity in our department.”

The AIMBE selected Chang Liu, associate professor, for his efforts in the fields of synthetic biology and directed evolution through the invention of in vivo hypermutation systems. He engineers specialized genetic systems that continuously and rapidly mutate user-selected genes in vivo. These systems allow researchers to evolve proteins at unprecedented speed, scale and depth in order to engineer new protein functions, probe the rules of evolution and understand the fundamental sequence-function relationships governing proteins and other macromolecules.

“I am delighted to be elected into the fellowship and look forward to fruitful interactions and endeavors with other members,” said Liu.

Professor Wendy Liu was recognized for contributions and service to the cell and tissue engineering community and advancing the field of immune cell mechanobiology. She uses bioengineering approaches to understand how the microenvironment regulates immune cell plasticity and immune-mediated wound healing. She is studying macrophages, innate immune cells that adopt a spectrum of functional phenotypes depending on their context and play a major role in wound healing and disease.

“I am honored and excited to receive this recognition from AIMBE,” she said. “I am also extremely grateful for the wonderful colleagues at UCI who have provided a supportive environment, and all of my collaborators and students who have contributed to our work.”

AIMBE’s mission is to recognize excellence, advance public understanding, and accelerate medical and biological innovation. Its College of Fellows includes over 1,500 honorees who work in academia, industry, clinical practice and government. The formal induction ceremony will be held during AIMBE’s 2022 Annual Event on March 25.

Read more on the UCI Samueli School of Engineering website.

https://bli.uci.edu/wp-content/uploads/2022/08/2022-aimbe-fellows.png 600 600 Gabrielle Comfort https://www.bli.uci.edu/wp-content/uploads/2017/09/white_transparent-1.png Gabrielle Comfort2022-02-18 15:37:002022-08-19 15:38:38Four Biomedical Engineering Faculty Named AIMBE Fellows

SPIE names Michael Berns as its 2022 Gold Medal winner

January 13, 2022/ News /by Gabrielle Comfort

Professor Berns is co-founder of the Beckman Laser Institute and a Professor at University of California, Irvine.

By Photonics World

SPIE has announced that its 2022 SPIE Gold Medal winner is Michael Berns, co-founder and founding director of the Beckman Laser Institute & Medical Clinic and a professor of biomedical engineering, surgery, and developmental and cell biology at the University of California, Irvine.

The SPIE Gold Medal is the highest honor the Society bestows. It is awarded in recognition of outstanding engineering or scientific accomplishments in optics, photonics, electro-optics, or imaging technologies and applications.

Berns is widely known as the “the father of laser microbeams,” due, in part, to his seminal work delineating how the laser can perform subcellular surgery on chromosomes. With an overarching approach that focuses on light interactions with cells and tissues, his research works to address biomedical problems such as nervous-system repair at single-cell level, a laser-leveraging technique that extends to degenerative diseases such as Parkinson’s, Alzheimer’s, and Huntington’s.

Multiple roles and recognitions

Among other roles, Berns oversees Beckman’s Cellular Biophotonics Laboratory, as well as serving as the director of the recently established Michael and Robert Berns Laser Microbeam Program.

Berns’ many recognitions include being elected as a Fellow of the Royal Society of Medicine in the UK in 2021. He is a Fellow of the British Royal Society of Biology, the Royal Norwegian Society of Sciences and Letters, and the American Association for the Advancement of Science as well as being an SPIE Fellow.

In 1994, he received the UCI medal, the highest honor awarded at UCI; in 2006, he received the SPIE Biomedical Optics Lifetime Achievement Award. He currently sits on the editorial board of the SPIE Journal of Biomedical Optics.

“Michael Berns’ work over several decades has set the international benchmark for the particular use of the laser for various studies in biomedicine,” says University of St. Andrews’ School of Physics and Astronomy Professor Kishan Dholakia.

“He has consistently performed and delivered breakthrough science that has stood the test of time, and is, quite simply, a highly prolific and agenda-setting international scientist of the highest quality. I have been most impressed with his passion and rigor at scientific meetings, which is an inspiration to audiences, and key to his success in teaching, training, and mentoring young researchers.

“In addition, the strategic value and impact of Berns’ work with regard to international science has been outstanding. The collaboration of his group at UCI with Professor Halina Rubinsztein-Dunlop and her group at the University of Queensland, for example, has led to an exceptional and prolific union of two of the leading photonics laboratories in the world.

“The complementary partnership has led to very exciting and highly productive trans-Pacific interdisciplinary research. The impact of Berns’ own work and that with collaborators supports the future of the field through the training and exchange of graduate students and post-docs.”

Read full article on optics.org.

https://www.bli.uci.edu/wp-content/uploads/2017/09/white_transparent-1.png 0 0 Gabrielle Comfort https://www.bli.uci.edu/wp-content/uploads/2017/09/white_transparent-1.png Gabrielle Comfort2022-01-13 11:24:002022-08-19 11:38:25SPIE names Michael Berns as its 2022 Gold Medal winner

Savvy New Tech, 10/6/21: Dr. Elliot Botvinick with iGlobe multianalyte sensor

October 6, 2021/ News /by Gabrielle Comfort

I posted about Dr. Elliot Botvinick from the University of California Irvine who is developing a multianalyte sensor called iGlobe.  It is unique and exciting and funded, for development by the Leona M. and Harry B. Helmsley Charitable Trust.

Dr. Elliot Botvinick, PhD is Professor, Samueli School of Engineering, BioEngineering, Surgery, Beckman Laser Institute and Medical Clinic and The Edwards Lifesciences Center for Advanced Cardiovascular Technology. iGlobe: He was awarded a 3-year, $3.5 million grant, along with Dr. Gregory Weiss, Professor of Chemistry, from the Helmsley Charitable Trust for the development of the iGlobe, first of its kind device to simultaneously measure insulin, glucose, oxygen and ketones with a single probe inserted just beneath the skin.

Named the UCI Samueli School of Engineering “Innovator of the Year” and “Entrepreneurial Leader of the Year for several years running, Dr. Botvinick holds more than 20 invention reports and lots more than 10 patents. Dr. Botvinick earned his Ph.D., M.S., and B.S. in bioengineering from the University of California, San Diego. He’s a dynamic and very enthusiastic scientist … and he is an amazing friend to the entire T1D community.

Just this week, Dr. Botvinick did a wonderful presentation to the DIY looping community as well as those in the T1D communities.  Hope you enjoy this!

Read more on The Savvy Diabetic.

https://bli.uci.edu/wp-content/uploads/2021/10/Z9A2136z72-1000.jpg 667 1000 Gabrielle Comfort https://www.bli.uci.edu/wp-content/uploads/2017/09/white_transparent-1.png Gabrielle Comfort2021-10-06 15:20:002022-08-19 15:30:08Savvy New Tech, 10/6/21: Dr. Elliot Botvinick with iGlobe multianalyte sensor

Gratton Receives Award for Pioneering Work

October 4, 2021/ News /by Gabrielle Comfort

The International Society for Optics and Photonics (SPIE) recognized ENRICO GRATTON with the 2021 Britton Chance Biomedical Optics Award at the SPIE Photonics West virtual conference. The award cited Gratton’s significant contributions to biophotonics – the science of producing and utilizing photons or light to image, identify and engineer biological materials. SPIE specifically noted his development of innovative ultrafast optical imaging and spectroscopy methods and their integration into microfluidic platforms.

This award was “a great honor” for Gratton who considers Chance, for whom the award was named, a “great friend.” In his conference presentation, Gratton shared his experiences meeting Chance, a National Academy of Sciences member and Olympic gold medalist in sailing who died in 2010, and doing research together.

Gratton is a professor of biomedical engineering and principal investigator for UCI’s Laboratory for Fluorescence Dynamics. A pioneer in the field of biomedical optics, Gratton’s achievements include development of the following technologies: multifrequency phase fluorometry, pulsed-source methods for frequency-domain fluorescence spectroscopy, generalized polarization to study cell membranes, spectral fluorescence lifetime measurements for cell physiology, photo-density waves, quantitative tissue oximetry with near-infrared spectroscopy and optical brain imaging.

During his more than 40-year career, Gratton has disseminated his work to researchers worldwide, trained younger scientists and interfaced successfully with industry. Under his guidance, more than 50 students have earned doctorates, with most currently occupying critical roles in academia and research institutions.

Read full article in UCI Department of Biomedical Engineering Discovery magazine.

https://bli.uci.edu/wp-content/uploads/2022/08/gratton-tv.png 360 540 Gabrielle Comfort https://www.bli.uci.edu/wp-content/uploads/2017/09/white_transparent-1.png Gabrielle Comfort2021-10-04 11:34:002022-08-19 11:37:20Gratton Receives Award for Pioneering Work

Berns Recognized for Biomedical Optics Contributions

October 4, 2021/ News /by Gabrielle Comfort

MICHAEL BERNS, Distinguished Professor Emeritus of biomedical engineering with a joint appointment in developmental and cell biology, and co-founder and founding director of UCI Beckman Laser Institute & Medical Clinic, has been elected as a Fellow of the Royal Society of Medicine in the United Kingdom.

Berns was invited to join the society based on his extensive biomedical optics contributions in the fields of biology and medicine. “I am truly honored to be invited to join the Royal Society, especially because it’s the same society that has honored so many elite luminaries of the past,” said Berns.

The mission of the organization is to advance health, through education and innovation. Fellows and Foreign Members of the Royal Society of Medicine are elected for life through a peer review process membership and governance. Famous Fellows include Charles Darwin, Louis Pasteur,
Edward Jenner and Sigmund Freud. Elected Fellows of the British Royal Society of Medicine are comparable to members of the National Academy of Medicine in the United States.

Click here to read UCI Department of Biomedical Engineering Discovery magazine.

https://bli.uci.edu/wp-content/uploads/2021/10/Copy-of-NY-Times-Article-Natasha-3.png 1200 2000 Gabrielle Comfort https://www.bli.uci.edu/wp-content/uploads/2017/09/white_transparent-1.png Gabrielle Comfort2021-10-04 11:09:002022-08-19 11:23:37Berns Recognized for Biomedical Optics Contributions

Botvinick to Develop First-of-its-Kind Diabetes Monitor

October 4, 2021/ News /by Gabrielle Comfort

Elliot Botvinick, professor of biomedical engineering, has been awarded a three-year, $3.5 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to further the development of an innovative continuous-use monitor for those with Type 1 diabetes. The first-of-its kind device will simultaneously measure insulin, glucose, lactate, oxygen and the ketone body beta-hydroxybutyrate with a single probe inserted just beneath the skin.

Called iGLOBE (Insulin + Glucose + Lactate + Oxygen + Beta-HydroxybutyratE) LifeStrip, the monitor utilizes light and chemistry to provide sensing capabilities for multiple analytes, which can be critical for controlling blood glucose and detecting possible dangerous events. The device will include continuous insulin monitoring and improve dosing efficacy by providing real-time feedback on the dynamics of insulin-pump therapy as well as real-time estimates of a patient’s sensitivity to the insulin.

It is also important to monitor blood glucose in those with Type 1 diabetes, known as insulin dependent diabetes. When blood glucose is elevated above normal values, called hyperglycemia, the body produces a chemical called beta-hydroxybutyrate. Elevated beta-hydroxybutyrate is associated with diabetic ketoacidosis, a dangerous condition, which can result in hospitalization or death. iGLOBE monitors this chemical to indicate dangerous levels and ensure automated insulin delivery functions properly.

Monitoring lactate, produced during exercise, is also important, as it can indicate changing metabolic states, which can lead to changes in blood glucose hours after exercise. This will improve glucose prediction and improve insulin dosing. “Clinical evidence suggests that both beta-hydroxybutyrate and insulin sensing would improve outcomes and decrease the rates of hospitalization, severe morbidity and death associated with hypo- and hyperglycemia,” said Botvinick, who is also associate director of UCI’s Edwards Lifesciences Center for Advanced Cardiovascular Technology and professor of surgery at UCI Beckman Laser Institute (BLI).

The addition of beta-hydroxybutyrate and insulin monitoring capabilities has the potential to be life-altering. “When taken together, glucose, lactate, beta-hydroxybutyrate and insulin monitoring can transform the care of people with Type 1 diabetes,” Botvinick said. “iGLOBE can improve glucose control, compensate for glucose variations associated with exercise, inform of possible or current diabetic ketoacidosis and inform of failing or failed insulin delivery.”

Botvinick is collaborating with Gregory Weiss, UCI professor of chemistry, molecular biology and biochemistry; and David O’Neal, M.D., professor of endocrinology at Australia’s University of Melbourne. The team includes John Weidling, BLI associate project scientist, and biomedical engineering graduate students Toni Wilkinson and Dat Nguyen.

Click here to read UCI Department of Biomedical Engineering Discovery magazine.

https://bli.uci.edu/wp-content/uploads/2022/08/Elliot-Botvinick.jpg 1053 1600 Gabrielle Comfort https://www.bli.uci.edu/wp-content/uploads/2017/09/white_transparent-1.png Gabrielle Comfort2021-10-04 10:55:002022-08-19 11:07:59Botvinick to Develop First-of-its-Kind Diabetes Monitor

Nature Methods Profiles Michelle Digman

August 19, 2021/ News /by Gabrielle Comfort

She connects equity, samurai swords, imaging and an automated way to count and track mitochondria.

by Vivien Marx / Nature Methods
Photo credit: E. Digman

Aug. 19, 2021 – “My path to faculty was definitely not standard or straight,” says Michelle Digman, who is on the faculty of the Department of Biomedical Engineering at the University of California, Irvine (UCI), where she develops imaging techniques, shapes the department’s policies on equity matters and does outreach programs for local community college and high school students from minorities under-represented in science. She co-directs the Laboratory for Fluorescence Dynamics, directs the W.M. Keck Nanoimaging Laboratory and was recently named an Allen Distinguished Investigator for a bioluminescence imaging project she is working on with UCI colleague Jennifer Prescher.

After obtaining her Ph.D. degree in chemistry at the University of Illinois, Chicago, she was a postdoctoral fellow in the physics lab of Enrico Gratton at the university’s Urbana-Champaign campus. Then she followed Gratton’s move to UCI, where she completed her fellowship. Next, she became scientific director of UCI’s optical core. “I like helping people,” she says.

After a few years, though, she missed developing and using advanced imaging to pursue her own research and began the hunt for a faculty post. But it was right during a US economic downturn. Interviews took place but universities followed up to notify her that, as a result of the downturn, they could not hire after all. “I didn’t lose hope, though,” she says. Her multi-disciplinary background seemed a blemish. Even in an age that prizes interdisciplinary projects, she heard reactions in the vein of: “You’re not really a chemist or you’re not really a biologist,” she says. “It was just really hard to feel like I belonged in a department.” That changed when she started applying for posts in biomedical engineering. Universities liked her background in chemistry, physics, biology and computing.

Despite other offers, she decided to stay in Irvine, where she had already found collaborators. Staying would accelerate her ability to set up her lab, she says, and help her students “hit the ground running.” In her first year as principal investigator, she had five Ph.D. students. She welcomes people into her lab from diverse training backgrounds.

From this diverse lab now comes Mitometer: software to automate the way mitochondria are segmented and tracked in live-cell imaging and to avoid needing to piece together a computational pipeline of several tools. Digman is happy that Mitometer can capture the structure and size of mitochondria, count fission and fusion events, continuously track mitochondria, and capture their motility and velocity. Such information can be connected to metabolic data.

Mitochondria give scientists a workout. “Sometimes mitochondria can get clustered in one particular spot,” she says, which gets in the way of accurate counting. “If you want to count them, the algorithms will just count the blob as one gigantic spot.” Austin Lefebvre, a Ph.D. student in Digman’s lab, worked out a way to apply fluorescence intensity thresholds to remove image noise. The software loops through images to computationally locate the mitochondria. The team applied Mitometer to synthetic data and then to confocal images of breast cancer cells and found that cancerous and non-cancerous cells differed in motility and morphology. They connected that information to metabolic differences found using fluorescence lifetime imaging. Tumor cells and non-tumor cells differ in the free and bound ratio of the coenzyme NADH, which is important in cellular energy production. This hints at potential ways to target mitochondria for therapeutic purposes.

Of her future plans, Digman says, “We would like to use Mitometer a lot more.” And she hopes it can be used in other labs. Neuroscientists could use it to track mitochondrial journeys in long axons, she says. After collecting a time-lapse image series and setting some parameters, labs should find the system easy to use. “Austin has made this platform, let’s say, anyone-proof.”

Anyone should also be able to enter science, which is why she has set up, in her lab, a summer week for local community college and high school students from groups under-represented in science. Observing the students, Digman says, “I think they are really transformed.” Their tasks relate to work in her and other UCI labs. For example, they have explored using fluorescence lifetime imaging to detect how macrophage types differ in terms of metabolism.

Beyond these activities, Digman practices the martial art of iaido, an ancient samurai-sword-drawing technique from Japan. The movements are intended to look and feel effortless. “It’s almost a meditative art form for me,” she says. Iaido is a way to develop strength and to practice a traditional martial art. “The purpose is to display an ultimate level of true and pure beauty.”

Says cell biologist Rick Horwitz, “Michelle has this extraordinary ability to bridge complex biophysical technologies with cutting edge biological problems.” Digman spent part of her postdoctoral fellowship in his lab at the University of Illinois. Others attempt such bridges without understanding the methods, or they marry methods with mundane biological problems or fail to grasp nuances of experimental cell and molecular biology, says Horwitz who is senior advisor and inaugural executive director emeritus of the Allen Institute for Cell Science.

Digman has “the magic” to make projects happen and the collaborative spirit to bring community with her, he says. “Unlike some outstanding scientists, Michelle is a wonderful colleague—generous, helpful, collaborative, a real team player, and liked by everyone.”

Click here to read the full article on the UCI Samueli School of Engineering website.

https://bli.uci.edu/wp-content/uploads/2023/01/digman-nature-methods.png 482 600 Gabrielle Comfort https://www.bli.uci.edu/wp-content/uploads/2017/09/white_transparent-1.png Gabrielle Comfort2021-08-19 12:17:002023-01-04 12:22:49Nature Methods Profiles Michelle Digman

In Memoriam: Distinguished Professor Emeritus Michael Berns

August 16, 2021/ News /by Gabrielle Comfort

By Lori Brandt, UCI Samueli School of Engineering Michael Berns, UC Irvine Distinguished Professor Emeritus of Surgery and Biomedical Engineering, died at his home in Irvine on Saturday, Aug. 13, 2022. The founding director of the UCI Beckman Laser Institute and Medical Clinic served on the UCI faculty for nearly half a century. Berns earned his undergraduate and graduate degrees from Cornell University in 1964 and 1968, respectively. He came to UCI from the University of Michigan in 1973. He served as chair of the Department of Developmental and Cell Biology within the School of Biological Sciences, and also held appointments in the School of Medicine and Samueli School of Engineering. Berns co-founded, with Arnold Beckman, the Beckman Laser Institute and Medical Clinic in 1982 and served as its director until 2003. He was the Arnold and Mabel Beckman Professor from 1988-2020. Berns also founded the first Laser Microbeam Program and the UCI Photonic Incubator. According to biomedical engineering department Chair Zoran Nenadic, in an email to the department staff and faculty, “Although a cell biologist by training, Michael was keenly aware that modern biological discoveries would be increasingly reliant on technological solutions. When Dr. Arnold Beckman showed up at Michael’s lab on a rainy morning four decades ago, he was fascinated by Michael’s work on laser microscopy and immediately recognized its potential. His endowment led to the creation of the world-renowned Beckman Laser Institute.” Berns was also instrumental in pursuing the formation of UCI’s BME department. “Since a great deal of his work was in engineering and there was no bioengineering department at UCI, Michael, together with Bruce Tromberg and Steve George, had a vision to create one,” wrote Nenadic. “In 1998, they applied to the Whitaker Foundation Development Award, which was responsible for seeding many bioengineering/biomedical engineering departments nationwide. While easily the least developed program at the time, this group of enthusiasts shocked the BME world by winning the award. Michael, who was the principal investigator on the proposal, and the research infrastructure that he had built at the BLI were instrumental in persuading the reviewers.” Berns’ pioneering work focused on the use of laser technology in medical and biological research. He developed tools and techniques for the surgical use of lasers, down to the level of manipulating single cells and individual chromosomes. He published extensively on the use of lasers in both biomedical research and medical treatment of illnesses, including skin disorders, vascular disease, eye problems and cancer. He was an elected fellow/member in numerous scientific and engineering societies, including the Royal Society of Biology of Great Britain, the Academy of the Royal Norwegian Academy of Sciences and Letters, the American Association for the Advancement of Science, the American Institute for Medical and Biological Engineering, and the American Society for Laser Medicine and Surgery. Most recently, Berns was recognized by the International Society for Optics and Photonics with the 2022 SPIE Gold Medal. In 1994, he was awarded the UCI Medal – the highest award at UCI for outstanding career achievements. His scientific achievements were numerous and impactful. His work has been cited over 26,000 times, spanning the fields of developmental biology, DNA repair, mechanobiology, the cytoskeleton, fertility, preservation of endangered species and immunology, to name just a few. Berns mentored former BLI director and current National Institute of Biomedical Imaging and Bioengineering Director Bruce Tromberg, as well as several UCI professors, including Vasan Venugopalan, Elliot Botvinick and Daryl Preece. “He artfully blended strong leadership with kindness, care and generosity toward budding scientists of all ages,” said Nenadic. “He will be dearly missed.” Said UCI Chancellor Howard Gillman, in a message to the campus community, “Michael Berns will be greatly missed by his friends and professional colleagues around the world. The entire university community joins me in sending condolences to his devoted children, Greg and Tammy.” Read the full article on the UCI Samueli School of Engineering website.

https://bli.uci.edu/wp-content/uploads/2022/08/Berns-profile-image-768x512-1.jpg 512 768 Gabrielle Comfort https://www.bli.uci.edu/wp-content/uploads/2017/09/white_transparent-1.png Gabrielle Comfort2021-08-16 10:01:002026-04-24 13:28:56In Memoriam: Distinguished Professor Emeritus Michael Berns

Karthik Prasad, 2021 ASLMS Research Grant Recipient

June 25, 2021/ News /by R. Diaz

The American Society for Laser Medicine and Surgery (ASLMS) Announces the 2021 Student Research Grant Recipients

ASLMS supports research projects designed to foster the development and use of lasers and other related technologies in medical and surgical applications.  This year, Karthik Prasad, a medical student at the UCI Beckman Laser Institute and Medical Clinic, under the support of ASLMS member and BLIMC faculty Dr. Brian Wong, has received an ASLMS 2021 Student Research Grant for his research “Multimodal Optical Characterization of Electromechanical Corneal Reshaping.”

For more information, please click here.

https://bli.uci.edu/wp-content/uploads/2021/06/ASLMS.jpg 188 450 R. Diaz https://www.bli.uci.edu/wp-content/uploads/2017/09/white_transparent-1.png R. Diaz2021-06-25 14:46:242021-06-25 14:53:23Karthik Prasad, 2021 ASLMS Research Grant Recipient

Botvinick Wins Grant to Develop Advanced Monitor for Type 1 Diabetes

April 6, 2021/ News /by Gabrielle Comfort

By: Anna Lynn Spitzer, UCI Samueli School of Engineering

April 6, 2021 – UC Irvine’s Elliot Botvinick, professor of biomedical engineering, has been awarded a three-year, $3.5 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to further the development of an innovative continuous-use monitor for those with Type 1 diabetes. The first-of-its-kind device will simultaneously measure insulin, glucose, lactate, oxygen and the ketone body beta-hydroxybutyrate with a single probe inserted just beneath the skin.

Called iGLOBE (Insulin + Glucose + Lactate + Oxygen + Beta-HydroxybutyratE) LifeStrip, the monitor utilizes light and chemistry to provide sensing capabilities for multiple analytes, which can be critical for controlling blood glucose and detecting possible dangerous events in those with the disease. The device will include continuous insulin monitoring and improve dosing efficacy by providing real-time feedback on the dynamics of insulin-pump therapy as well as real-time estimates of a patient’s sensitivity to the insulin.

It is also important to monitor blood glucose in those with Type 1 diabetes, also known as insulin dependent diabetes. When blood glucose is elevated above normal values, a condition called hyperglycemia, the body produces a chemical called beta-hydroxybutyrate through a metabolic reaction. Elevated beta-hydroxybutyrate is associated with diabetic ketoacidosis, a dangerous condition, which can result in hospitalization or death. iGLOBE monitors this chemical both as a “smoke alarm” to indicate dangerous levels and as an additional test to ensure automated insulin delivery is functioning properly.

Monitoring lactate, produced during exercise, is important as well, as it can indicate changing metabolic states, which can lead to changes in blood glucose in the hours after exercise. Knowledge of such metabolic shifts will improve glucose prediction and improve insulin dosing.

“Clinical evidence suggests that both beta-hydroxybutyrate and insulin sensing would improve outcomes and decrease the rates of hospitalization, severe morbidity and death associated with hypo- and hyperglycemia,” said Botvinick, who is also associate director of UCI’s Edwards Lifesciences Center for Advanced Cardiovascular Technology and a professor of surgery at UCI Beckman Laser Institute (BLI).

Botvinick is collaborating with Gregory Weiss, UCI professor of chemistry, molecular biology and biochemistry, who is managing the project’s protein chemistry and protein engineering aspects, including development of insulin-sensing films; and David O’Neal M.D., professor of endocrinology at Australia’s University of Melbourne, where the device ultimately will undergo animal and human trials. The team includes John Weidling, BLI associate project scientist, and biomedical engineering graduate students Toni Wilkinson and Dat Nguyen.

The device includes an insertion system that allows the thin fiber sensor to be inserted by a spring-loaded custom needle, which users will place just beneath the skin, either in the abdomen or the upper arm. Researchers also will generate designs for mass-manufacturing capability and assembly, ensuring that processes adhere to FDA guidelines.

Botvinick believes his group’s multi-analyte system is the first of its kind. The work is a continuation of a current device developed by his team that includes sensors for glucose, lactate and oxygen; its primary advantage over commercially available and emerging products is the relative ease by which analyte-measurement pads can be added without significantly increasing the size of the probe.

The addition of beta-hydroxybutyrate and insulin monitoring capabilities has the potential to be life-altering. “When taken together, glucose, lactate, beta-hydroxybutyrate and insulin monitoring can transform the care of people with type 1 diabetes,” Botvinick said. “iGLOBE can improve glucose control, compensate for glucose variations associated with exercise, inform of possible or current diabetic ketoacidosis and inform of failing or failed insulin delivery.”

The Leona M. and Harry B. Helmsley Charitable Trust aspires to improve lives by supporting exceptional efforts in the U.S. and around the world in health and select place-based initiatives. It has awarded more than $3 billion since its inception in 2008.

Read full article on the UCI Samueli School of Engineering website.

https://bli.uci.edu/wp-content/uploads/2021/04/78I3660.jpg 1707 2560 Gabrielle Comfort https://www.bli.uci.edu/wp-content/uploads/2017/09/white_transparent-1.png Gabrielle Comfort2021-04-06 15:52:002021-04-28 15:58:53Botvinick Wins Grant to Develop Advanced Monitor for Type 1 Diabetes
Page 23 of 32«‹2122232425›»
Search Search

Categories

  • News
FOLLOW US ON SOCIAL MEDIA
  • Link to X_icon
  • Link to Facebook
  • Link to LinkedIn
  • Link to Youtube
  • Link to Instagram
  • Support BLIMC❤️
  • Contact US
  • For Staff
Scroll to top Scroll to top Scroll to top
Loading...

Insert/edit link

Enter the destination URL

Or link to existing content

    No search term specified. Showing recent items. Search or use up and down arrow keys to select an item.